These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8537164)

  • 21. Proscar (Finasteride) inhibits 5 alpha-reductase activity in the ovaries and testes of Lytechinus variegatus Lamarck (Echinodermata: Echinoidea).
    Wasson KM; Watts SA
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Oct; 120(3):425-31. PubMed ID: 9827060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential activities of androgen metabolizing enzymes in human prostate.
    Krieg M; Weisser H; Tunn S
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):395-400. PubMed ID: 7542902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of topical finasteride suggests an endocrine role for dihydrotestosterone.
    Price TM; Allen S; Pegram GV
    Fertil Steril; 2000 Aug; 74(2):414-5. PubMed ID: 10927075
    [No Abstract]   [Full Text] [Related]  

  • 24. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
    Délos S; Carsol JL; Ghazarossian E; Raynaud JP; Martin PM
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):375-83. PubMed ID: 8541234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
    Spinucci G; Pasquali R
    Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of finasteride on human testicular steroidogenesis.
    Castro-Magana M; Angulo M; Fuentes B; Canas A; Sarrantonio M; Arguello R; Vitollo P
    J Androl; 1996; 17(5):516-21. PubMed ID: 8957695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers.
    Strauch G; Perles P; Vergult G; Gabriel M; Gibelin B; Cummings S; Malbecq W; Malice MP
    Eur Urol; 1994; 26(3):247-52. PubMed ID: 7805711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
    Schwartz JI; Van Hecken A; De Schepper PJ; De Lepeleire I; Lasseter KC; Shamblen EC; Winchell GA; Constanzer ML; Chavez CM; Wang DZ; Ebel DL; Justice SJ; Gertz BJ
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2942-7. PubMed ID: 8768856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA; Hordinsky M; Whiting D; Stough D; Hobbs S; Ellis ML; Wilson T; Rittmaster RS;
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolism of testosterone by dermal papilla cells cultured from human pubic and axillary hair follicles concurs with hair growth in 5 alpha-reductase deficiency.
    Hamada K; Thornton MJ; Laing I; Messenger AG; Randall VA
    J Invest Dermatol; 1996 May; 106(5):1017-22. PubMed ID: 8618032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors.
    Iehlé C; Délos S; Guirou O; Tate R; Raynaud JP; Martin PM
    J Steroid Biochem Mol Biol; 1995 Sep; 54(5-6):273-9. PubMed ID: 7577710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydrotestosterone stimulates 5 alpha-reductase activity in pubic skin fibroblasts.
    Mowszowicz I; Melanitou E; Kirchhoffer MO; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1983 Feb; 56(2):320-5. PubMed ID: 6218182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
    Olsen EA
    Exp Dermatol; 1999 Aug; 8(4):302-3. PubMed ID: 10439233
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
    Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
    Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 5-alpha-reductase inhibition on sex-hormone-binding globulin in elderly men.
    Jaffe A; Matzkin H; Gilad S; Stern N
    Horm Res; 1994; 41(5-6):215-7. PubMed ID: 7525442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism.
    Moghetti P; Castello R; Magnani CM; Tosi F; Negri C; Armanini D; Bellotti G; Muggeo M
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1115-21. PubMed ID: 7962284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
    Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
    Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
    Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
    J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.